ScanBalt Business Club Partner Search: A preclinical efficacy service provide with proven track record of intranasal delivery needed
An Estonian pharmaceutical company is looking to utilize nose to brain pathway for delivery of one of their drugs. A preclinical efficacy service provide with proven track record of intranasal delivery is needed to support the program. Validated intranasal administration method in rats should be in place. They can consider other species if reliable procedure is established.
Contact:
Maarika Merirand Biotechnology Manager of the Connected Health Cluster Tallinn Science Park Tehnopol E: +372 51 781 87 +971 50 206 42 40
ScanBalt News
17 April 2024
COBIOE project consortium opens an interconnection platform for the European biomanufacturing sector
12 March 2024
19th National Conference on Health Economy 2024 | 30-31 May 2024 | Mecklenburg-Vorpommern, Germany